Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 National Biotechnology Conference
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Poster Title
Home
Browse by Poster Title
Browse by Poster Title
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Sort by
#
Sort by
Title
A
M1330-01-02
A Robust Adoptive Cell Therapy Phenotyping Panel for Assessing Cerebrospinal Fluid During and After Neurotoxicity by Flow Cytometry
Favorite
T1430-01-04
A Sensitive Electrochemiluminescence-Based Method for the Detection of Anti-drug Antibodies against Anti-PD-1 Antibody Drug Pembrolizumab in Human Serum
Favorite
M1330-01-07
A Translational Approach for Measuring Bi-specific Anti-Drug Antibodies in Non-Clinical Studies Using a Drug Tolerant Generic Plug and Play Format
Favorite
M1430-01-03
Achieving Drug Tolerance in a Multiplexed Neutralizing Antibody Assay (nAb) Using Competition and Heat Solid Phase Extraction (SPE) Conditions
Favorite
T1430-01-01
Alginate Hydrogels: A Tunable Tool for Biotech Applications
Favorite
M1130-01-01
An Adjuvanted Microparticulate Microneedle-Based Gonorrhea Vaccine Induced a Robust Immune Response in Mice
Favorite
T1430-01-09
An Orthogonal Bioanalytical Approach to Assess the Immunogenicity and Efficacy of Covid-19 Vaccines
Favorite
M1430-01-08
Antibody Titration: Titer Cut-Point or Screening Cut-Point: Which One Is a Practical Option?
Favorite
M1330-01-05
Application of Mitra Microsampling for the Quantitative Bioanalysis of Antisense Oligonucleotides
Favorite
M1430-01-02
Approaches for Reducing the Environmental Impact and Increasing the Throughput of Bioanalytical LC Separations
Favorite
T1030-01-05
Assessing the Feasibility and Impact of Singlicate-Based Analysis for Clinical ADA Sample Analysis
Favorite
B
T1430-01-03
Bioanalytical Cross Validation: A More Statistically Based Approach to Establish Differences between Bioanalytical Methods and Laboratories
Favorite
M1430-01-04
Brain-Targeted Delivery of Plasmid DNA Encoding for Angiotensin II Receptor shRNA to Manage Neurogenic Hypertension
Favorite
M1430-01-06
Bridging of a Duplex to Singleplex bDNA Method to Quantitate mRNA from LNP-mRNA-ABC in Human Serum
Favorite
C
T1130-01-05
CARTs - A New Vehicle for Nucleic Acid Delivery with a Unique Controllable Release Mechanism
Favorite
T1330-01-04
Characterization and In Vivo Evaluation of Oil Based Anti-adhesion Agent with Xanthan Gum
Favorite
M1130-01-07
Characterization of Critical Reagents Used in Immunogenicity Analysis: Case Studies from NAb Assays
Favorite
M1330-01-08
Comparing the Efficacy of Intranasal Midazolam, Diazepam and Lorazepam as First-Line Treatments of Acute Seizures: Pilot Investigation in Pilocarpine-Induced Mice Model
Favorite
M1030-01-04
Comprehensive Assessment of Immunogenicity Risk of Host Cell Proteins in Biologics Using In Silico and In Vitro Methods
Favorite
T1030-01-08
Conjugation Chemistry Used to Construct Protein-Coated Nanoparticles Determines Complement Activation and Associated Efficacy and Toxicity
Favorite
T1130-01-07
Current Strategies for Using Commercial Kit in Regulated Bioanalysis
Favorite
D
T1030-01-06
Detection and Quantification of AAV Genome: Effects of Sample Pretreatment and Cross Platform Comparison of ddPCR and qPCR
Favorite
M1330-01-01
Developing a Generic ADA Assay for the Detection of Circulating Immune Complexes Using a Fully Automated Microfluidic Immunoassay System
Favorite
T1130-01-06
Development and Optimization of Next-Generation Lipid Nanoparticles for In Situ CAR-T Production
Favorite
M1130-01-09
Development of an In Vitro Cell Culture Model for Evaluation of Influenza Vaccine Formulated Using Spray-Dried Albumin Nanoparticles
Favorite
M1430-01-01
Discrepancies in Adeno-Associated Virus Serotype and Isotype Characterization Positivity Rates in Cynomolgus Serum
Favorite
E
M1030-01-07
E. coli Nissle 1917-Based Bacterial Cell Therapy Helps Restore Intestinal Barrier and Improve Post-Myocardial Infarction Outcomes
Favorite
T1130-01-09
Effect of Different Types of Dendrobium on the Gut Microbiota Alteration and Anti-diabetic Effect: In Vitro Screening and In Vivo Verification in db/db Mice
Favorite
M1130-01-08
Establishment of a Generic ADA Assay for Detection of Anti-Drug Antibody Specific to Human IgG Derived Drug Candidate in Murine Serum Samples
Favorite
T1130-01-02
Evaluating a Merged Well Analysis Strategy for Validation of a Cellular Kinetics Assay to Quantify an Allogeneic Cell Product in Human Blood by ddPCR
Favorite
T1030-01-07
Evaluation of Formation of SpyTag Form of Botulinum Toxin A (BoNT/A) by Electrochemiluminescence Sandwich Immunoassay
Favorite
F
M1330-01-03
FM1000 Surfactant is Compatible with Downstream Bioprocessing
Favorite
H
T1330-01-03
Harnessing Dendritic Cell Migration as a Predictor of Subcutaneous Immunogenicity Risk in a Mechanism-Based Screening Tool
Favorite
M1330-01-04
High-Throughput and Selective LC-MS Quantitation of SMARCA2/4 for SMARCA2 Targeted Protein Degrader Cross-Species Pharmacodynamics Analysis
Favorite
I
M1030-01-02
Identification and Characterization of Impurities in Lipid Nanoparticle Components Using TOF-MS with Predictive In Silico Fragmentation and Automated Data Processing
Favorite
M1430-01-05
Immunocapture LC-MS/MS Assay for the Biomarker, Troponin Fast (TNNI2) Using a Specific Antibody
Favorite
T1430-01-07
Importance of Quality Control of In Vitro Transcribed RNA
Favorite
M1330-01-06
In Vitro Assessment of Physicochemical Properties of Biologics for the Early Identification of Pharmacokinetic Liabilities in a Developability Workflow
Favorite
M1030-01-06
Investigating the Impact of a Soluble Target on ADA Measurements in a Bispecific Antibody Clinical Study
Favorite
L
T1130-01-08
Labelling AAV5 Capsid Reduced Its Binding Affinity to the Anti-AAV5 Antibody in Non-primate Human Serum Samples
Favorite
M
M1030-01-01
Measuring Free IgE in Low-Affinity Interaction with Omalizumab Using an Automated Microfluidic Immunoassay to Support Pharmacokinetics and Pharmacodynamics Studies
Favorite
T1430-01-05
Mechanistic Investigation of Side-Effects of Lung Tropic Lipid Nanoparticles
Favorite
T1030-01-02
Modification of Particle and Hardware Surfaces for Efficient Biotherapeutic Method Development
Favorite
M1030-01-03
Monodisperse Fully Porous Particles (MFPP) for Use in Increasing Resolution in Liquid Chromatography
Favorite
M1130-01-05
Multi-factored Immunogenicity Risk Assessment Approach for Bispecific Immune Cell Engagers
Favorite
T1430-01-06
Multiple Root Causes Impact Methionine Oxidation in a Coformulated Drug Product
Favorite
T1330-01-08
Multiplexed Quantification of CAR-T Subtypes by PCR
Favorite
M1130-01-02
Multiscale Pharmacokinetic Modeling and Simulation of Local and Systemic Exposure of Intramuscularly Injected LNPs
Favorite
P
T1330-01-07
Preparation and Evaluation of Protein Encapsulated Liposome Using Surfactant for Dry Powder Inhalation
Favorite
T1430-01-02
Preparation of PEG-b-PLA Nanoparticles via Inline Sonication for Controlled Release Applications
Favorite
Q
M1030-01-08
Quantitation of Diazepam and Its Metabolites Using High-Throughput Rapidfire Mass Spectrometry
Favorite
S
T1330-01-02
Screening and Epitope Binning of Anti-idiotypic Antibodies against Therapeutic Bispecific Antibodies Using the Gyros Immunoassay Platform
Favorite
T1030-01-01
Selectivity of Human Cytokine Quantification in Human and Cyno Serum Using a Fully Automated Microfluidic Immunoassay System
Favorite
T1430-01-08
Sensitization of Paclitaxel-Induced Apoptosis by Echinops giganteus Extract via Downregulation of PI3K/Akt/NF-κB Pathway and Enrichment of TIMP-3 in Cervical Cancer
Favorite
T1030-01-04
Short-Term Tacrolimus/Sirolimus Combination Therapy Induces Long-Term Immune Tolerance to a Human Monoclonal Antibody in Rats
Favorite
T1330-01-01
ST266 Amnion-Derived Mutipotent Cell Secretome for Prevention and Treatment of Necrotizing Enterocolitis
Favorite
T1130-01-01
Strategies for Measuring Oligonucleotides Using a Fully Automated Microfluidic Immunoassay System
Favorite
M1130-01-06
Structural Profiling of mRNA Vaccine Constructs: Applications for mRNA Vaccine Design and Quality Assessment
Favorite
T
T1030-01-03
Tolerization with a Novel Tim Agonist Dual-Acting Liposomal Formulation Prepares the Immune System for the Success of Gene Therapy
Favorite
U
M1030-01-05
Use of Technical Replicate Precision Acceptance for qPCR- and ddPCR-based Validations and Sample Testing
Favorite
V
T1130-01-04
Validation of an Anti-drug Antibody (ADA) Assay Using the Mitra VAMS Microsampling Technology in Support of a Phase I Clinical Study
Favorite
T1330-01-06
Validation of PBPK-Based Translation to Predict Monoclonal Antibody Pharmacokinetics in Pediatric Populations
Favorite
T1030-01-09
Virtual Screening of SARS Cov 2 Papain Like Protease Inhibitors
Favorite
X
M1130-01-04
XenoImmune™ Mouse Model, a Novel and Proprietary Animal Model that Recapitulates Clinical Immunogenicity Rates of Biologics
Favorite
